BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9202386)

  • 21. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.
    Kornmann M; Ishiwata T; Matsuda K; Lopez ME; Fukahi K; Asano G; Beger HG; Korc M
    Gastroenterology; 2002 Jul; 123(1):301-13. PubMed ID: 12105858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb.
    Revest JM; Suniara RK; Kerr K; Owen JJ; Dickson C
    J Immunol; 2001 Aug; 167(4):1954-61. PubMed ID: 11489975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo.
    Mailleux AA; Spencer-Dene B; Dillon C; Ndiaye D; Savona-Baron C; Itoh N; Kato S; Dickson C; Thiery JP; Bellusci S
    Development; 2002 Jan; 129(1):53-60. PubMed ID: 11782400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney.
    Cancilla B; Ford-Perriss MD; Bertram JF
    Kidney Int; 1999 Dec; 56(6):2025-39. PubMed ID: 10594778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of mammary gland differentiation in transgenic mice by the fatty acid-binding protein MRG.
    Wang M; Liu YE; Goldberg ID; Shi YE
    J Biol Chem; 2003 Nov; 278(47):47319-25. PubMed ID: 12975368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
    Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity.
    Rousseau B; Larrieu-Lahargue F; Javerzat S; Guilhem-Ducléon F; Beermann F; Bikfalvi A
    Cancer Res; 2004 Apr; 64(7):2490-5. PubMed ID: 15059903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of expression of the KGF receptor and its ligands KGF and FGF-10 during postnatal mouse mammary gland development.
    Pedchenko VK; Imagawa W
    Mol Reprod Dev; 2000 Aug; 56(4):441-7. PubMed ID: 10911393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4.
    Revest JM; Spencer-Dene B; Kerr K; De Moerlooze L; Rosewell I; Dickson C
    Dev Biol; 2001 Mar; 231(1):47-62. PubMed ID: 11180951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.
    Saunier E; Dif F; Kelly PA; Edery M
    Endocrinology; 2003 Jun; 144(6):2669-75. PubMed ID: 12746331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse.
    Ohkubo Y; Uchida AO; Shin D; Partanen J; Vaccarino FM
    J Neurosci; 2004 Jul; 24(27):6057-69. PubMed ID: 15240797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.
    Jones FE; Stern DF
    Oncogene; 1999 Jun; 18(23):3481-90. PubMed ID: 10376526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
    Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
    Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development.
    Xie W; Paterson AJ; Chin E; Nabell LM; Kudlow JE
    Mol Endocrinol; 1997 Nov; 11(12):1766-81. PubMed ID: 9369445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.
    Browaeys-Poly E; Cailliau K; Vilain JP
    Eur J Biochem; 2000 Oct; 267(20):6256-63. PubMed ID: 11012680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysis.
    Belluardo N; Wu G; Mudo G; Hansson AC; Pettersson R; Fuxe K
    J Comp Neurol; 1997 Mar; 379(2):226-46. PubMed ID: 9050787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9.
    Agrotis A; Kanellakis P; Kostolias G; Di Vitto G; Wei C; Hannan R; Jennings G; Bobik A
    J Biol Chem; 2004 Oct; 279(40):42221-9. PubMed ID: 15292181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system.
    Miraux S; Lemière S; Pineau R; Pluderi M; Canioni P; Franconi JM; Thiaudière E; Bello L; Bikfalvi A; Auguste P
    Angiogenesis; 2004; 7(2):105-13. PubMed ID: 15516831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.